Influenza challenge successfully completed
For the proof-of-principle, influenza A/PR/8/34 VLPs carrying four parental proteins were tested in a mouse challenge model. Final results show that Redbiotec’s influenza-VLPs effectively protect the immunized mice against the parental challenge virus. Please contact Redbiotec (raehle@redbiotec.ch) for more information to these study results.
Redbiotec signs exploratory study with Intercell AG
Redbiotec has entered into a cooperation with Intercell AG (Vienna, Austria), in which Redbiotec will apply its proprietary technology platform rePAX™ to an undisclosed discovery area. Check Redbiotec news site for more information.
